Ocular Therapeutix, Inc.

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Dextenza in the Post-op Management of Vitreoretinal Surgeries	Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms	Recruiting	Phase 4	2026-07-29	NCT04371445
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study	Neovascular Age-Related Macular Degeneration (nAMD)	Recruiting	Phase 3	2026-07-01	NCT07516132
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy	background diabetic retinopathy	Recruiting	Phase 3	2026-03-16	NCT07235085
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration	Neovascular Age-related Macular Degeneration	Active, not recruiting	Phase 3	2025-06-17	NCT06495918
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration	Neovascular Age-Related Macular Degeneration	Active, not recruiting	Phase 3	2025-04-18	NCT06223958
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery	Patient Preference	Recruiting	Phase 4	2019-12-20	NCT04205916

Clinical trials